30/07/2015 16:18:09 Free Membership Login

Edwards Lifesciences News (NYSE:EW)

DateTimeSource
Headline
07/30/20154:01PMPRNUSEdwards Announces Board Change
Edwards Announces Board Change PR Newswire IRVINE, Calif., July 30, 2015 IRVINE, Calif., July 30, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Robert A. Ingram has retired from the company's Board of Directors... More...>>
07/28/20154:01PMPRNUSEdwards Lifesciences Reports Second Quarter Results
Edwards Lifesciences Reports Second Quarter Results - Second Quarter Underlying Sales Growth of 18% and Reported Growth of 7% - 2015 THV Underlying Sales Growth Guidance Raised to 25% to 35% - 2015 Non-GAAP EPS Guidance Now $4.30 to $4.40 PR Newswire IRVINE, Calif., July 28, 2015 IRVINE, Calif., July 28, 2015 /PRNewswire/... More...>>
07/14/201510:00AMPRNUSEdwards Lifesciences to Host Earnings Conference Call on July 28, 2015
Edwards Lifesciences to Host Earnings Conference Call on July 28, 2015 PR Newswire IRVINE, Calif., July 14, 2015 IRVINE, Calif., July 14, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, plans to announce its operating results... More...>>
07/10/20155:00PMPRNUSEdwards Lifesciences Enters Into Agreement To Acquire CardiAQ
Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ PR Newswire IRVINE, Calif., July 10, 2015 IRVINE, Calif., July 10, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ... More...>>
06/17/20157:07PMPRNUSEdwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve
Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve Approved For High-Risk Indication and All Valve Sizes PR Newswire IRVINE, Calif., June 17, 2015 IRVINE, Calif., June 17, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic... More...>>
06/12/20158:07AMTMF3 Medical Device Stocks to Watch
http://www.fool.com/investing/general/2015/06/12/3-medical-device-stocks-to-watch.aspx?source=eptadnlnk0000002 More...>>
06/08/20156:58AMPRNUSEdwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor
Edwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor PR Newswire PARIS, June 8, 2015 PARIS, June 8, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr... More...>>
06/03/20154:22PMPRNUSEdwards Lifesciences to Present at Goldman Sachs 36th Annual Global Healthcare Conference
Edwards Lifesciences to Present at Goldman Sachs 36th Annual Global Healthcare Conference PR Newswire IRVINE, Calif., June 3, 2015 IRVINE, Calif., June 3, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present... More...>>
06/03/20159:00AMPRNUSEdwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor
Edwards Heart Valve Pioneer Starr Receives Prestigious Scientific Honor PR Newswire PARIS, June 3, 2015 PARIS, June 3, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today congratulated trusted Edwards partner Dr. Albert Starr... More...>>
05/20/201512:15PMTMFWhat Is the S&P 500 Index?
http://www.fool.com/investing/general/2015/05/20/what-is-the-sp-500-index.aspx?source=eptadnlnk0000002 More...>>
05/20/20154:30AMPRNUSSAPIEN 3 Valve Again Demonstrates Low Mortality, Excellent 30-Day Outcomes In Intermediate-Risk Patients
SAPIEN 3 Valve Again Demonstrates Low Mortality, Excellent 30-Day Outcomes In Intermediate-Risk Patients PR Newswire PARIS, May 20, 2015 PARIS, May 20, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that 30-day... More...>>
05/19/201511:40AMDJNEdwards Lifesciences Temporarily Pauses Study
Edwards Lifesciences Corp. said Tuesday it is voluntarily implementing a temporary pause on enrollment in an early study of its experimental Fortis mitral heart valves that are implanted or repaired via catheters instead of open-heart surgery. The Irvine, Calif.-based maker of nonsurgical heart valves said evidence of... More...>>
05/19/20159:19AMPRNUSEdwards Pauses Enrollment In Early Stage Mitral Program
Edwards Pauses Enrollment In Early Stage Mitral Program PR Newswire IRVINE, Calif., May 19, 2015 IRVINE, Calif., May 19, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that in consultation with trial investigators... More...>>
05/19/20158:45AMPRNUSFirst One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate
First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate PR Newswire PARIS, May 19, 2015 PARIS, May 19, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that... More...>>
05/07/201510:00AMPRNUSEdwards Lifesciences To Webcast Annual Meeting Of Stockholders
Edwards Lifesciences To Webcast Annual Meeting Of Stockholders PR Newswire IRVINE, Calif., May 7, 2015 IRVINE, Calif., May 7, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, will host its Annual Meeting of Stockholders on Thursday... More...>>
04/27/20159:34AMARNEdwards Lifesciences Corp Price Target Raised to $140.00 at Deutsche Bank (EW)
http://tickerreport.com/banking-finance/475633/edwards-lifesciences-corp-price-target-raised-to-140-00-at-deutsche-bank-ew/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/26/20154:13AMARNEdwards Lifesciences Corp's "Buy" Rating Reiterated at Canaccord Genuity (EW)
http://tickerreport.com/banking-finance/473736/edwards-lifesciences-corps-buy-rating-reiterated-at-canaccord-genuity-ew/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/26/20153:00AMARNEdwards Lifesciences Corp Earns "Neutral" Rating from BTIG Research (EW)
http://tickerreport.com/banking-finance/473580/edwards-lifesciences-corp-earns-neutral-rating-from-btig-research-ew/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/24/201510:28AMARNEdwards Lifesciences Corp Price Target Increased to $150.00 by Analysts at Barclays (EW)
http://tickerreport.com/banking-finance/472241/edwards-lifesciences-corp-price-target-increased-to-150-00-by-analysts-at-barclays-ew/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/23/20154:01PMPRNUSEdwards Lifesciences Reports First Quarter Results
Edwards Lifesciences Reports First Quarter Results - THV Performance Drove Sales Growth of 13%, Underlying Sales Grew 21% - Full Year 2015 Non-GAAP EPS Guidance Narrowed to $4.10 to $4.30 PR Newswire IRVINE, Calif., April 23, 2015 IRVINE, Calif., April 23, 2015 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE:... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse ew150730 16:18